Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Daridorexant 10 mg vs 25 mg Tablets in Healthy Japanese Participants
NCT05877222Phase 1Completed
- Sponsor
- Idorsia
- Start
- Jun 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of daridorexant in Insomnia (2 arms), sponsored by Idorsia. Primary endpoints: Maximum Plasma Concentration at Day 3 and Area Under the Plasma Concentration-Time Curve from Time Zero to Time t at Day 3. Started Jun 2023; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT05877222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05877222.